Treatment of Giardia lamblia infections.
Nash
T E
TE
Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
D000818:Animals; D000977:Antiparasitic Agents / Q000627:therapeutic use*; D005243:Feces / Q000469:parasitology; D005664:Furazolidone / Q000627:therapeutic use; D016829:Giardia lamblia; D005873:Giardiasis / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D010303:Paromomycin / Q000627:therapeutic use; D011796:Quinacrine / Q000627:therapeutic use
D000977:Antiparasitic Agents; D008795:Metronidazole; D005664:Furazolidone; D010303:Paromomycin; D011796:Quinacrine